Expression and significance of Rac1, Pak1 and Rock1 in gastric carcinoma

Asia-Pacific Journal of Clinical Oncology

Volumn 10, Issue 2, 2014, Pages

  Wu, Yong jun ^a   Tang, Yi ^a   Li, Zhen feng ^a   Li, Zheng ^a   Zhao, Yi ^a   Wu, Zhen jiang ^a   Su, Qi ^a  

^a UNIVERSITY OF SOUTH CHINA   (China)

Author keywords

Gastric neoplasm; Immunohistochemistry; Pak1; Rac1; Rock1; Tissue microarray

Indexed keywords

P21 ACTIVATED KINASE 1; RAC1 PROTEIN; RHO KINASE; ROCK1 PROTEIN; TUMOR MARKER; UNCLASSIFIED DRUG; P21 ACTIVATED KINASE; PAK1 PROTEIN, HUMAN; RAC1 PROTEIN, HUMAN; ROCK1 PROTEIN, HUMAN;

ADULT; AGED; ARTICLE; CANCER STAGING; CANCER SURGERY; CLINICAL FEATURE; CONTROLLED STUDY; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SEX RATIO; STOMACH CANCER; STOMACH CARCINOMA; STOMACH EPITHELIUM; TISSUE MICROARRAY; TUMOR DIFFERENTIATION; BIOSYNTHESIS; DISEASE COURSE; ENZYMOLOGY; METABOLISM; MIDDLE AGED; PATHOLOGY; PROGNOSIS; STOMACH TUMOR; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; DISEASE PROGRESSION; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; P21-ACTIVATED KINASES; PROGNOSIS; RAC1 GTP-BINDING PROTEIN; RHO-ASSOCIATED KINASES; STOMACH NEOPLASMS; TISSUE ARRAY ANALYSIS; TUMOR MARKERS, BIOLOGICAL;

EID: 84901618189     PISSN: 17437555     EISSN: 17437563     Source Type: Journal    
DOI: 10.1111/ajco.12052     Document Type: Article

References (28)

1. Gómez del Pulgar T, Bandrés E, Espina C etal. Differential expression of Rac1 identifies its target genes and its contribution to progression of colorectal cancer. Int J Biochem Cell Biol 2007; 39: 2289-2302.
2. Rathinam R, Berrier A, Alahari SK. Role of Rho GTPases and their regulators in cancer progression. Front Biosci 2011; 17: 2561-2571.
3. Kumar R, Vadlamudi RK. Emerging functions of p21-activated kinases in human cancer cells. J Cell Physiol 2002; 193: 133-144.
4. Ong CC, Jubb AM, Haverty PM etal. Targeting p21-activated kinase 1 (PAK1) to induce apoptosis of tumor cells. Proc Natl Acad Sci U S A 2011; 108: 7177-7182.
5. Liu X, Choy E, Hornicek FJ etal. ROCK1 as a potential therapeutic target in osteosarcoma. J Orthop Res 2011; 29: 1259-1266.
6. Bosman FT, Carneiro F, Hruban RH, Theise ND. World Health Organization Classification of Tumours of the Digestive System. International Agency for Research on Cancer, Lyons 2010; 1-155.
7. Wang JX, Zhou YN, Zou SJ, Ren TW, Zhang ZY. Correlations of P21-activated kinase 1 expression to clinicopathological features of gastric carcinoma and patients prognosis. Chin J Cancer 2010; 29: 649-654.
8. Stengel K, Zheng Y. Cdc42 in oncogenic transformation, invasion, and tumorigenesis. Cell Signal 2011; 23: 1415-1423.
9. Prasain N, Stevens T. The actin cytoskeleton in endothelial cell phenotypes. Microvasc Res 2009; 77: 53-63.
10. Baranwal S, Alahari SK. Rho GTPase effector functions in tumor cell invasion and metastasis. Curr Drug Targets 2011; 12: 1194-1201.
11. Arias-Romero LE, Chernoff J. P21-activated kinases in Erbb2-positive breast cancer: a new therapeutic target. Small Gtpases 2010; 1: 124-128.
12. Schnelzer A, Prechtel D, Knaus U etal. Rac1 in human breast cancer: overexpression, mutation analysis, and characterization of a new isoform, Rac1b. Oncogene 2000; 19: 3013-3020.
13. Binker MG, Binker-Cosen AA, Richards D, Gaisano HY, de Cosen RH, Cosen-Binker LI. Hypoxia-reoxygenation increase invasiveness of PANC-1 cells through Rac1/MMP-2. Biochem Biophys Res Commun 2010; 393: 371-376.
14. Spindler V, Waschke J. Role of Rho GTPases in desmosomal adhesion and pemphigus pathogenesis. Ann Anat 2011; 193: 177-180.
15. Pavey S, Zuidervaart W, van Nieuwpoort F etal. Increased p21-activated kinase-1 expression is associated with invasive potential in uveal melanoma. Melanoma Res 2006; 16: 285-296.
16. Yang Z, Bagheri-Yarmand R, Wang RA etal. The epidermal growth factor receptor tyrosine kinase inhibitor ZD 1839 (Iressa) suppresses c-Src and Pakl pathways and invasiveness of human cancer cells. Clin Cancer Res 2004; 10: 658-667.
17. Arber S, Barbayannis FA, Hanser H etal. Regulation of actin dynamics through phosphorylation of cofilin1 by LIM-kinase. Nature 1998; 393: 805-809.
18. Okada T, Lopez-Lago M, Giancotti FG. Merlin/NF-2 mediates contact inhibition of growth by suppressing recruitment of Rac to the plasma membrane. J Cell Biol 2005; 171: 361-371.
19. Carter JH, Douglass LE, Deddens JA etal. Pak-1 expression increases with progression of colorectal carcinomas to metastasis. Clin Cancer Res 2004; 10: 3448-3456.
20. Lou Z, Billadeau DD, Savoy DN, Schoon RA, Leibson PJ. A role for a RhoA/ROCK1/LIM-kinase pathway in the regulation of cytotoxic lymphocytes. J Immunol 2001; 167: 5749-5757.
21. Ozawa T, Araki N, Yunoue S etal. The neurofibromatosis type 1 gene product neurofibromin enhances cell motility by regulating actin filament dynamics via the Rho-ROCK-LIMK2-cofilin pathway. J Biol Chem 2005; 280: 39524-39533.
22. Wu YJ, Tang Y, Li Z etal. Clinicopathological significance of cofilin1 in gastric cancer. Chin J Clin Exp Pathol 2011; 27: 658-660.
23. Schmitz AA, Govek EE, Böttner B etal. Rho GTPases: signaling, migration, and invasion. Exp Cell Res 2000; 261: 1-1.
24. Delorme V, Machacek M, DerMardirossian C etal. Cofilin1 activity downstream of Pak1 regulates cell protrusion efficiency by organizing lamellipodium and lamella actin networks. Dev Cell 2007; 13: 646-662.
25. Hall A, Rho GTPases and the actin cytoskeleton. Science 1998; 279: 509-514.
26. Edwards DC, Sanders LC, Bokoch GM etal. Activation of LIM-kinase by Pak1 couples Rac/Cdc42 GTPase signalling to actin cytoskeletal dynamics. Nat Cell Biol 1999; 1: 253-259.
27. Kamai T, Tsujii T, Arai K etal. Significant association of Rho/ROCK1 pathway with invasion and metastasis of bladder cancer. Clin Cancer Res 2003; 9: 2632-2641.
28. Ohashi K, Nagata K, Maekawa M etal. Rho-associated kinase ROCK1 activates LIM-kinase 1 by phosphorylation at threonine 508 within the activation loop. J Biol Chem 2000; 275: 3577-3582.